Abstract
Fibrinogen is a plasma glycoprotein and one of the principle participants in blood coagulation. It interacts with many proteins during formation of a blood clot, including insulin-like growth factors (IGFs) and their binding proteins (IGFBP). Fibrinogen complexes were found as minor fractions in fibrinogen preparations independently of the coagulation process, and their presence influences the kinetics of polymerization. The idea of this work was to investigate whether fibrinogen in human plasma interacts with IGFBPs independently of the tissue injury or coagulation process. The results have shown that fibrinogen forms complexes with IGFBP-1 under physiological conditions. Several experimental approaches have confirmed that complexes are co-isolated with fibrinogen from plasma, they are relatively stable, and they appear as a general feature of human plasma. Several other experiments excluded the possibility that alpha-2 macroglobulin/IGFBP-1 complexes or IGFBP-1 oligomers contributed to IGFBP-1 immunoreactivity. The role of fibrinogen/IGFBP-1 complexes is still unknown. Further investigation in individuals expressing both impaired glucose control and coagulopathy could contribute to identification and understanding of their possible physiological role.
Similar content being viewed by others
Abbreviations
- ConA:
-
lectin from Canavalia ensiformis
- IGF:
-
insulin-like growth factor
- IGFBP:
-
IGF-binding protein
- PBS:
-
phosphate buffered saline
References
Schmidt, D., and Brennan, S. O. (2007) Modified form of the fibrinogen Bβ chain (des-Gln Bβ), a potential longlived marker of pancreatitis, Clin. Chem., 53, 2105–2111.
Tennent, G. A., Brennan, S. O., Stangou, A. J., O’Grady, J., Hawkins, P. N., and Pepys, M. B. (2007) Human plasma fibrinogen is synthesized in the liver, Blood, 109, 1971–1974.
Chapin, J. C., and Hajjar, K. A. (2015) Fibrinolysis and the control of blood coagulation, Blood Rev., 29, 17–24.
McMullin, N. R., Kauvar, D. S., Currier, H. M., Baskin, T. W., Pusateri, A. E., and Holcomb, J. B. (2006) The clinical and laboratory response to recombinant factor VIIa in trauma and surgical patients with acquired coagulopathy, Curr. Surg., 63, 246–251.
Asselta, R., Duga, S., and Tenchini, M. L. (2006) The molecular basis of quantitative fibrinogen disorders, J. Thromb. Haemost., 4, 2115–2129.
Becatti, M., Marcucci, R., Bruschi, G., Taddei, N., Bani, D., Gori, A. M., Giusti, B., Gensini, G. F., Abbate, R., and Fiorillo, C. (2014) Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction, Arterioscler. Thromb. Vasc. Biol., 34, 1355–1361.
Dunn, E. J., Philippou, H., Ariens, R. A. S., and Grant, P. J. (2006) Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus, Diabetologia, 49, 1071–1080.
Brennan, S. O. (2015) Variation of fibrinogen oligosaccharide structure in the acute phase response: possible hemorrhagic implications, Biochim. Biophys. Acta, 3, 221–226.
Scott, E. M., Ariens, R. A. S., and Grant, P. J. (2004) Genetic and environmental determinants of fibrin structure and function, Arterioscler. Thromb. Vasc. Biol., 24, 1558–1566.
Schneider, D. J., Taatjes, D. J., Howard, D. B., and Sobel, B. E. (1999) Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein, J. Am. Coll. Cardiol., 33, 261–266.
Makogonenko, E., Tsurupa, G., Ingham, K., and Medved, L. (2002) Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectinbinding site, Biochemistry, 41, 7907–7913.
Dowling, P., Palmerini, V., Henry, M., Meleady, P., Lynch, V., Ballot, J., Gullo, G., Crown, J., Moriarty, M., and Clynes, M. (2014) Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients, Biochim. Biophys. Acta, 2, 24–30.
Talens, S., Leebeek, F. W. G., Demmers, J. A. A., and Rijken, D. C. (2012) Identification of fibrin clot-bound plasma proteins, PLoS One, 7, e41966.
Sahni, A., Simpson-Haidaris, P. J., Sahni, S. K., Vaday, G. G., and Francis, C. W. (2008) Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2), J. Thromb. Haemost., 6, 176–183.
Martino, M. M., Briquez, P. S., Ranga, A., Lutolf, M. P., and Hubbell, J. A. (2013) Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix, Proc. Natl. Acad. Sci. USA, 110, 4563–4568.
Haase, I., Evans, R., Pofahl, R., and Watt, F. M. (2003) Regulation of keratinocyte shape, migration and wound epithelialization by IGF-1and EGF-dependent signaling pathways, J. Cell Sci., 116, 3227–3238.
Werner, S., and Grose, R. (2003) Regulation of wound healing by growth factors and cytokines, Physiol. Rev., 83, 835–870.
Annunziata, M., Granata, R., and Ghigo, E. (2011) The IGF system, Acta Diabetol., 48, 1–9.
LeRoith, D., and Roberts, C. T., Jr. (2003) The insulin-like growth factor system and cancer, Cancer Lett., 195, 127–137.
Firth, S. M., and Baxter, R. C. (2002) Cellular actions of the insulin-like growth factor binding proteins, Endocrinol. Rev., 23, 824–854.
Lee, P. D. K., Conover, C. A., and Powell, D. R. (1993) Regulation and function of insulin-like growth factor-binding protein-1, Exp. Biol. Med., 204, 4–29.
Marcinkiewicz, M., and Gordon, P. V. (2008) A role for plasmin in platelet aggregation: differential regulation of IGF release from IGF-IGFBP complexes? Growth Horm. IGF Res., 18, 325–334.
Campbell, P. G., Novak, J. F., Yanosick, T. B., and McMaster, J. H. (1992) Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex, Endocrinology, 130, 1401–1412.
Campbell, P. G., Durham, S. K., Hayes, J. D., Suwanichkul, A., and Powell, D. R. (1999) Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin, J. Biol. Chem., 274, 30215–30221.
Huang, L., and Lord, S. T. (2013) The isolation of fibrinogen monomer dramatically influences fibrin polymerization, Thromb. Res., 131, 258–263.
Cohn, E. J., Strong, L. E., Hughes, W. L., Jr., Mulford, D. J., Ashworth, J. N., Melin, M., and Taylor, H. L. (1946) Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids, J. Am. Chem. Soc., 63, 459–475.
Fowell, A. H. (1955) Turbidimetric method of fibrinogen assay, Am. J. Clin. Pathol., 25, 340–342.
Lagundzin, D., Masnikosa, R., Miljus, G., Robajac, D., and Nedic, O. (2010) An investigation of the different molecular forms of IGFBP-1 using immobilized metal-, immuno-, and lectin-affinity chromatography, J. Serb. Chem. Soc., 75, 1481–1489.
Westwood, M., Aplin, J. D., Collinge, I. A., Gill, A., White, A., and Gibson, J. M. (2001) α2-Macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis, J. Biol. Chem., 276, 41668–41674.
Sunderic, M., Malenkovic, V., and Nedic, O. (2015) Complexes between insulin-like growth factor binding proteins and alpha-2-macroglobulin in patients with tumor, Exp. Mol. Pathol., 98, 173–177.
Shibuya, H., Sakai, K., Kabir-Salmani, M., Wachi, Y., and Iwashita, M. (2011) Polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) potentiates IGF-I actions in placenta, J. Cell. Physiol., 226, 434–439.
Sakai, K., Busby, W. H., Jr., Clarke, J. B., and Clemmons, D. R. (2001) Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1 ability to inhibit insulin-like growth factor-I-stimulated protein synthesis, J. Biol. Chem., 276, 8740–8745.
Masnikosa, R., Zivkovic, B., and Nedic, O. (2009) IGFBP-1 forms associates with placental cell membranes, J. Serb. Chem. Soc., 74, 707–716.
Dunn, S., and Spiro, R. (1967) The α2-macroglobulin of human plasma, J. Biol. Chem., 242, 5549–5555.
Adamczyk, B., Struwe, W. B., Ercan, A., Nigrovic, P. A., and Rudd, P. M. (2013) Characterization of fibrinogen glycosylation and its importance for serum/plasma N-glycome analysis, J. Proteome Res., 12, 444–454.
Krusius, T., Finne, J., and Rauvala, H. (1976) The structural basis of the different affinities of two types of acidic Nglycosidic glycopeptides for concanavalin A-Sepharose, FEBS Lett., 71, 117–120.
Rajaram, S., Baylink, D. J., and Mohan, S. (1997) Insulinlike growth factor-binding proteins in serum and other biological fluids: regulation and functions, Endocrinol. Rev., 18, 801–831.
Hwa, V., Oh, Y., and Rosenfeld, R. G. (1999) The insulinlike growth factor-binding protein (IGFBP) superfamily, Endocrinol. Rev., 20, 761–787.
Weber, M. M., Spottl, G., Gossl, C., and Engelhardt, D. (1999) Characterization of human insulin-like growth factor-binding proteins by two-dimensional polyacrylamide gel electrophoresis and western ligand blot analysis, J. Clin. Endocrinol. Metab., 84, 1679–1684.
Hjortebjerg, R., and Frystyk, J. (2013) Determination of IGFs and their binding proteins, Best Pract. Res. Clin. Endocrinol. Metab., 27, 771–781.
Brandt, K., Grunler, J., Brismar, K., and Wang, J. (2015) Effects of IGFBP-1 and IGFBP-2 and their fragments on migration and IGF-induced proliferation of human dermal fibroblasts, Growth Horm. IGF Res., 25, 34–40.
Jones, J., Gockerman, A., Busby, W. H., Jr., Wright, G., and Clemmons, D. R. (1993) Insulin-like growth factor binding protein 1 stimulates cell migration and bind to the α5β1 integrin by means of its Arg-Gly-Asp sequence, Proc. Natl. Acad. Sci. USA, 90, 10553–10557.
Ramos-Mozo, P., Rodriguez, C., Pastor-Vargas, C., Blanco-Colio, L. M., Martinez-Gonzalez, J., Meilhac, O., Michel, J.-B., Vega De Cenga, M., Egido, J., and MartinVentura, J. L. (2012) Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm, Atherosclerosis, 221, 544–550.
Kobayashi, M., Kawase, T., Horimizu, M., Okuda, K., Wolff, L. F., and Yoshie, H. (2012) A proposed protocol for the standardized preparation of PRF membranes for clinical use, Biologicals, 40, 323–329.
Aneke-Nash, C. S., Parrinello, C. M., Rajpathak, S. N., Rohan, T. E., Strotmeyer, E. S., Kritchevsky, S. B., Psaty, B. M., Buzikova, P., Kizer, J. R., Newman, A. B., Strickler, H. D., and Kaplan, R. C. (2015) Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults, J. Am. Geriatr. Soc., 63, 902–909.
Carr, M. E. (2001) Diabetes mellitus a hypercoagulable state, J. Diabetes Complicat., 15, 44–54.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2016, Vol. 81, No. 2, pp. 231–237.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM15-283, December 27, 2015.
Rights and permissions
About this article
Cite this article
Gligorijević, N., Nedić, O. Interaction between fibrinogen and insulin-like growth factor-binding protein-1 in human plasma under physiological conditions. Biochemistry Moscow 81, 135–140 (2016). https://doi.org/10.1134/S0006297916020073
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297916020073